08:35 AM EDT, 05/14/2025 (MT Newswires) -- Invivyd ( IVVD ) said Wednesday that it has urged the US Food and Drug Administration to focus on monoclonal antibodies for the prevention of COVID-19 to rebuild Americans' trust in scientific data and public health recommendations.

The company said the citizen petition it filed with the FDA requested a re-evaluation of COVID-19 mRNA vaccines as well as new clinical trials to assess vaccine effectiveness.

Invivyd ( IVVD ) said it has also asked the US health regulator to make clear that biologics license application approval is appropriate based on serum virus neutralizing antibody titers.

The company's shares rose 7% in recent premarket activity on Wednesday.